Editorial: Nutritional approaches in chronic liver diseases.
作者信息
Rodríguez Villafuerte Santiago
机构信息
Department of Hepatology, Hospital Vozandes, Quito, Ecuador.
Directorate of Postgraduate Studies in Health Sciences, Universidad de las Américas, Quito, Ecuador.
出版信息
Front Nutr. 2024 Sep 13;11:1480541. doi: 10.3389/fnut.2024.1480541. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Nutritional approaches in chronic liver diseases.社论：慢性肝病的营养治疗方法
Front Nutr. 2024 Sep 13;11:1480541. doi: 10.3389/fnut.2024.1480541. eCollection 2024.
2
Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration.代谢相关脂肪性肝病：术语演变、诊断前沿和治疗视野的探索——述评。
World J Gastroenterol. 2024 May 14;30(18):2387-2390. doi: 10.3748/wjg.v30.i18.2387.
3
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study.代谢功能障碍相关脂肪性肝病及酒精摄入增加的代谢功能障碍相关脂肪性肝病会增加肝细胞癌和新发或失代偿期肝硬化的发生风险：一项韩国全国性研究
Liver Cancer. 2023 Dec 22;13(4):426-437. doi: 10.1159/000535943. eCollection 2024 Aug.
4
Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic.日本代谢相关脂肪性肝病：2019 年冠状病毒病大流行前 10 年的流行趋势及临床背景。
Medicina (Kaunas). 2024 Aug 16;60(8):1330. doi: 10.3390/medicina60081330.
5
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review.代谢功能障碍相关脂肪性肝病（MASLD）：最新综述
J Obes Metab Syndr. 2023 Sep 30;32(3):197-213. doi: 10.7570/jomes23052. Epub 2023 Sep 13.
6
Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease.植物源疗法治疗代谢功能障碍相关脂肪性肝病。
Int J Mol Sci. 2024 May 21;25(11):5571. doi: 10.3390/ijms25115571.
7
Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.代谢功能障碍相关脂肪性肝病相关肝细胞癌的表型
Clin Gastroenterol Hepatol. 2024 Sep;22(9):1774-1789.e8. doi: 10.1016/j.cgh.2024.03.028. Epub 2024 Apr 10.
8
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).EASL-EASD-EASO 临床实践指南：代谢功能障碍相关脂肪性肝病（MASLD）的管理。
Obes Facts. 2024;17(4):374-444. doi: 10.1159/000539371. Epub 2024 Jun 7.
9
From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus.从代谢功能障碍相关脂肪性肝病到代谢功能障碍相关脂肪性肝病：争议与共识
World J Hepatol. 2023 Dec 27;15(12):1253-1257. doi: 10.4254/wjh.v15.i12.1253.
10
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis.代谢功能障碍相关脂肪性肝病（MASLD）与肝硬化住院患者充血性心力衰竭风险增加的关联：一项倾向评分匹配分析
Cureus. 2024 Jun 15;16(6):e62441. doi: 10.7759/cureus.62441. eCollection 2024 Jun.
本文引用的文献
1
Global burden of liver disease: 2023 update.全球肝病负担：2023 年更新。
J Hepatol. 2023 Aug;79(2):516-537. doi: 10.1016/j.jhep.2023.03.017. Epub 2023 Mar 27.
2
Malnutrition in Patients with Liver Cirrhosis.肝硬化患者的营养不良。
Nutrients. 2021 Feb 7;13(2):540. doi: 10.3390/nu13020540.
3
ESPEN guideline on clinical nutrition in liver disease.ESPEN 临床肝病营养指南。
Clin Nutr. 2019 Apr;38(2):485-521. doi: 10.1016/j.clnu.2018.12.022. Epub 2019 Jan 16.
4
EASL Clinical Practice Guidelines on nutrition in chronic liver disease.EASL 临床实践指南：慢性肝病中的营养问题。
J Hepatol. 2019 Jan;70(1):172-193. doi: 10.1016/j.jhep.2018.06.024. Epub 2018 Aug 23.
5
Current status in the therapy of liver diseases.肝脏疾病治疗的现状。
Int J Mol Sci. 2014 Apr 30;15(5):7500-12. doi: 10.3390/ijms15057500.
6
Nutritional assessment in patients with cirrhosis.肝硬化患者的营养评估
Arq Gastroenterol. 2012 Jan-Mar;49(1):19-27. doi: 10.1590/s0004-28032012000100005.
Zotero 插件